178 related articles for article (PubMed ID: 29414387)
41. Quite a lot of smoke but very limited fire--the use of methamphetamine in Europe.
Griffiths P; Mravcik V; Lopez D; Klempova D
Drug Alcohol Rev; 2008 May; 27(3):236-42. PubMed ID: 18368604
[TBL] [Abstract][Full Text] [Related]
42. ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Farré M; Estivill X; Torrens M
Eur Neuropsychopharmacol; 2014 Mar; 24(3):420-4. PubMed ID: 24230997
[TBL] [Abstract][Full Text] [Related]
43. Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: a national drug abuse treatment clinical trials network study.
Wu LT; Blazer DG; Stitzer ML; Patkar AA; Blaine JD
Am J Addict; 2008; 17(4):304-11. PubMed ID: 18612886
[TBL] [Abstract][Full Text] [Related]
44. Why do we need an Addiction supplement focused on methamphetamine?
Rawson RA; Condon TP
Addiction; 2007 Apr; 102 Suppl 1():1-4. PubMed ID: 17493048
[TBL] [Abstract][Full Text] [Related]
45. Multi-Family Therapy with a Reflecting Team: A Preliminary Study on Efficacy among Opiate Addicts in Methadone Maintenance Treatment.
Garrido-Fernández M; Marcos-Sierra JA; López-Jiménez A; Ochoa de Alda I
J Marital Fam Ther; 2017 Apr; 43(2):338-351. PubMed ID: 27747887
[TBL] [Abstract][Full Text] [Related]
46. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
47. Role of ALDH5A1 in methadone treatment.
Torrens M; Fonseca F
Pharmacogenomics; 2014 Apr; 15(5):573-6. PubMed ID: 24798712
[No Abstract] [Full Text] [Related]
48. The Impact of Social Support and Attachment Style on Quality of Life and Readiness to Change in a Sample of Individuals Receiving Medication-Assisted Treatment for Opioid Dependence.
Cavaiola AA; Fulmer BA; Stout D
Subst Abus; 2015; 36(2):183-91. PubMed ID: 25839214
[TBL] [Abstract][Full Text] [Related]
49. [Long term effectiveness of methadone maintenance treatments in persons with addiction to opiates].
Bobes García J; Bobes Bascarán MT
Adicciones; 2012; 24(3):179-83. PubMed ID: 22868972
[TBL] [Abstract][Full Text] [Related]
50. Managing opioid dependence in pregnancy -- a general practice perspective.
Arunogiri S; Foo L; Frei M; Lubman DI
Aust Fam Physician; 2013 Oct; 42(10):713-6. PubMed ID: 24130973
[TBL] [Abstract][Full Text] [Related]
51. Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern.
Khoramizadeh M; Effatpanah M; Mostaghimi A; Rezaei M; Mahjoub A; Shishehgar S
Daru; 2019 Dec; 27(2):743-753. PubMed ID: 31228128
[TBL] [Abstract][Full Text] [Related]
52. Illicit Heroin and Methamphetamine Use among Methadone Maintenance Treatment Patients in Dehong Prefecture of Yunnan Province, China.
Wang R; Ding Y; Bai H; Duan S; Ye R; Yang Y; Wang J; Tang R; Gao M; He N
PLoS One; 2015; 10(7):e0133431. PubMed ID: 26196394
[TBL] [Abstract][Full Text] [Related]
53. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
54. Opioids and methamphetamine: a tale of two crises.
The Lancet
Lancet; 2018 Feb; 391(10122):713. PubMed ID: 29486928
[No Abstract] [Full Text] [Related]
55. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
[TBL] [Abstract][Full Text] [Related]
56. Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study.
Mayet A; Lions C; Roux P; Mora M; Maradan G; Morel A; Michel L; Marimoutou C; Carrieri MP
J Subst Abuse Treat; 2015 Nov; 58():100-5. PubMed ID: 26260134
[TBL] [Abstract][Full Text] [Related]
57. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study.
Noroozi A; Malekinejad M; Rahimi-Movaghar A
J Psychoactive Drugs; 2018; 50(3):214-223. PubMed ID: 29377788
[TBL] [Abstract][Full Text] [Related]
58. [Review of scientific evidence on alternatives to methadone in the psychopharmacologic treatment of opiate dependence].
Iruín A; Aizpurua I; Ruiz de Apodaka J; Zapiraín E; Aizpuru A
Rev Esp Salud Publica; 2001; 75(3):207-19. PubMed ID: 11515335
[TBL] [Abstract][Full Text] [Related]
59. Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.
Soyka M
Eur Addict Res; 2015; 21(2):78-87. PubMed ID: 25413371
[TBL] [Abstract][Full Text] [Related]
60. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
